title: Human papillomavirus type 11 (HPV-11) neutralizing antibodies in the serum and genital mucosal secretions of African green monkeys immunized with HPV-11 virus-like particles expressed in yeast.
abstract: It has been shown previously that immunization of animals with recombinant virus-like particles (VLPs) consisting of the viral capsid proteins L1 or L1 plus L2 protected animals against experimental viral challenge. However, none of these experimental models addresses the issue of whether systemic immunization with VLPs elicits a neutralizing antibody response in the genital mucosa. Such a response may be necessary to protect the uterine cervix against infection with genital human papillomavirus (HPV) types. African green monkeys systemically immunized with HPV-11 VLPs expressed in Saccharomyces cerevisiae and formulated on aluminum adjuvant elicited high-titered HPV-11 VLP-specific serum antibody responses. Sera from these immunized monkeys neutralized HPV-11 in the athymic mouse xenograft system. Significant levels of HPV-11-neutralizing antibodies also were observed in cervicovaginal secretions. These findings suggest that protection against HPV infection of the uterine cervix may be possible through systemic immunization with HPV VLPs.
authors.affiliation: Department of Virus and Cell Biology, Merck Research Laboratories, West Point, Pennsylvania 19486, USA.
authors.forename: R S
authors.initials: RS
authors.lastname: Lowe
authors.forename: D R
authors.initials: DR
authors.lastname: Brown
authors.forename: J T
authors.initials: JT
authors.lastname: Bryan
authors.forename: J C
authors.initials: JC
authors.lastname: Cook
authors.forename: H A
authors.initials: HA
authors.lastname: George
authors.forename: K J
authors.initials: KJ
authors.lastname: Hofmann
authors.forename: W M
authors.initials: WM
authors.lastname: Hurni
authors.forename: J G
authors.initials: JG
authors.lastname: Joyce
authors.forename: E D
authors.initials: ED
authors.lastname: Lehman
authors.forename: H Z
authors.initials: HZ
authors.lastname: Markus
authors.forename: M P
authors.initials: MP
authors.lastname: Neeper
authors.forename: L D
authors.initials: LD
authors.lastname: Schultz
authors.forename: A R
authors.initials: AR
authors.lastname: Shaw
authors.forename: K U
authors.initials: KU
authors.lastname: Jansen
mesh_terms: D000818:Animals; D000914:Antibodies, Viral / Q000097:blood*; D002522:Chlorocebus aethiops; D005260:Female; D018928:Immunity, Mucosal; D007114:Immunization; D007074:Immunoglobulin G / Q000097:blood; D027383:Papillomaviridae / Q000276:immunology*; D012441:Saccharomyces cerevisiae / Q000235:genetics; D014614:Vaccines, Synthetic / Q000276:immunology*; D014621:Vagina / Q000276:immunology*; D014765:Viral Vaccines / Q000276:immunology*; D014771:Virion / Q000276:immunology*
chemical_list: D000914:Antibodies, Viral; D007074:Immunoglobulin G; D014614:Vaccines, Synthetic; D014765:Viral Vaccines